BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biotech Failures 2026: What Did Not Happen in APAC Biopharma

01 October, 2026 | Analysis

Lilly’s Retatrutide Delivers 20.8% Weight Loss in Phase III Obesity and Type 2 Diabetes Trial

01 October, 2026 | News

Telix Secures FDA Fast Track Designation for BiPASS Prostate Cancer Imaging Programme

01 October, 2026 | News

Piramal Pharma Invests $5.3M to Expand Drug Substance Manufacturing in Canada

01 October, 2026 | Analysis

CAS and Novartis Partner to Build AI-Ready Reaction Data Platform for Drug Discovery

01 October, 2026 | News

Bio-Techne Opens Düsseldorf Flagship Centre to Accelerate Life Sciences Innovation Across Europe

New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise Regional hub will support researchers and organizations across the DACH and broader EMEA reg...

Lab

21 September, 2026 | Monday | News

OGT Expands SureSeq NGS Indexing Capacity to 384 Samples per Run

OGT, a leading global provider of genomic research and diagnostic solutions, announced the expansion of its SureSeq™ Universal NGS Unique Dual Index (UDI) range, enabling laboratories to multiplex up to 3...

BioTech

01 October, 2026 | Thursday | Analysis

Biotech Failures 2026: What Did Not Happen in APAC Biopharma

Approvals get counted, deals get ranked, listings get priced. The other half of the year, the programmes that stopped, the applications that came back, the partnerships that ended quietly in a footnote, rarely ...

Contract Services

29 September, 2026 | Tuesday | News

Vetter Accelerates Injectable Manufacturing Expansion to Meet Rising Global Demand

Vetter, a leading Contract Development and Manufacturing Organization (CDMO), continues to expand its commercial fill-and-finish network to further strengthen its global manufacturing operations and suppo...

Consumer Health

22 September, 2026 | Tuesday | News

DKSH Launches Colpofix in Singapore to Support Women with HPV-Related Cervical Lesions

Women in Singapore now have another option to support their cervical health following Human Papillomavirus (HPV) infection, with DKSH's launch of Colpofix®. The vaginal spray gel medical device is indicated...

Medtech

30 September, 2026 | Wednesday | News

iRegene Advances Off-the-Shelf Retinal Cell Therapy Into Clinical Trials in US and China

Following its Parkinson's disease program, iRegene advances another off-the-shelf cell therapy into clinical development in the U.S. and China. iRegene Therapeutics Co., Ltd. ("iRegene" or the "Company")...

Cell & Gene

30 September, 2026 | Wednesday | News

Biotech Failures 2026: What Did Not Happen in APAC Biopharma

Lilly’s Retatrutide Delivers 20.8% Weight Loss in Phase III Obesity and Type 2 Diabetes Trial

Telix Secures FDA Fast Track Designation for BiPASS Prostate Cancer Imaging Programme

Piramal Pharma Invests $5.3M to Expand Drug Substance Manufacturing in Canada

CAS and Novartis Partner to Build AI-Ready Reaction Data Platform for Drug Discovery

Bio-Techne Opens Düsseldorf Flagship Centre to Accelerate Life Sciences Innovation Across Europe

OGT Expands SureSeq NGS Indexing Capacity to 384 Samples per Run

Biotech Failures 2026: What Did Not Happen in APAC Biopharma

Vetter Accelerates Injectable Manufacturing Expansion to Meet Rising Global Demand

DKSH Launches Colpofix in Singapore to Support Women with HPV-Related Cervical Lesions

iRegene Advances Off-the-Shelf Retinal Cell Therapy Into Clinical Trials in US and China

iRegene Advances Off-the-Shelf Retinal Cell Therapy Into Clinical Trials in US and China

Biotech Failures 2026: What Did Not Happen in APAC Biopharma

Waters Launches BD FACSDiscover A7 Cell Analyzer to Expand Access to Advanced Flow Cytometry

The 10 Deals That Defined APAC Biopharma in 2026

Piramal Pharma Invests $5.3M to Expand Drug Substance Manufacturing in Canada

Stay Connected